Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
specificA B acute lymphoblastic leukemia that occurs during childhood. It is characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.
62
Centers
56
Active Trials
—
Cancer Funding
Top Centers for Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1(62)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 53.0 |
| 2 | NCI Comprehensive Active Research Program | 53.0 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 53.0 |
| 4 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 53.0 |
| 5 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.0 |
| 6 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 53.0 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 53.0 |
| 8 | NCI Comprehensive Active Research Program | 53.0 |
| 9 | NCI Comprehensive Active Research Program | 53.0 |
| 10 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 53.0 |
| 11 | NCI Comprehensive Active Research Program | 53.0 |
| 12 | NCI Comprehensive Active Research Program | 53.0 |
| 13 | NCI Comprehensive Active Research Program | 53.0 |
| 14 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 53.0 |
| 15 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 53.0 |
| 16 | NCI Comprehensive Active Research Program | 53.0 |
| 17 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 53.0 |
| 18 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.0 |
| 19 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 53.0 |
| 20 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.0 |
| 21 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.0 |
| 22 | NCI Clinical Active Research Program | 53.0 |
| 23 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.0 |
| 24 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 53.0 |
| 25 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 53.0 |
| 26 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 53.0 |
| 27 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 53.0 |
| 28 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.0 |
| 29 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 53.0 |
| 30 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.0 |
| 31 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 53.0 |
| 32 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 53.0 |
| 33 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 53.0 |
| 34 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.0 |
| 35 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 53.0 |
| 36 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 53.0 |
| 37 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 53.0 |
| 38 | Boston University Cancer CenterBoston, MA Active Research Program | 53.0 |
| 39 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 53.0 |
| 40 | Active Research Program | 53.0 |
| 41 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.0 |
| 42 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 53.0 |
| 43 | Penn State Cancer InstituteHershey, PA Active Research Program | 53.0 |
| 44 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 53.0 |
| 45 | Livestrong Cancer InstitutesAustin, TX Active Research Program | 53.0 |
| 46 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.0 |
| 47 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 53.0 |
| 48 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 53.0 |
| 49 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 53.0 |
| 50 | Active Research Program | 53.0 |
| 51 | Upstate Cancer CenterSyracuse, NY Active Research Program | 53.0 |
| 52 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 53.0 |
| 53 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 53.0 |
| 54 | Active Research Program | 53.0 |
| 55 | BC CancerVancouver, BC Active Research Program | 53.0 |
| 56 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 53.0 |
| 57 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 30.5 |
| 58 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 30.5 |
| 59 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive | 30.5 |
| 60 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 30.5 |
| 61 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 30.5 |
| 62 | NCI Comprehensive | 30.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →